Back
ESC Professional Premium Access

Reduction of major adverse and major cardiovascular events in patients with atrial fibrillation and stent implantation treated with left atrial occlusion device vs oral anticoagulants strategy.

Session: Pharmacology and bleeding/ischaemica trade-off
Topic: Left Atrial Appendage (LAA) Closure
Speaker: Professor J. Lopez-Minguez (Badajoz, ES)
Event: ESC Congress 2022

Congress Presentation

Add to my library

Like

About the speaker

Professor Jose Ramon Lopez-Minguez

University Hospital of Badajoz, Badajoz (Spain)
0 follower

6 more presentations in this session

Early in-hospital discontinuation of aspirin following coronary stent implantation in patients with indication for direct oral anticoagulation

Speaker: Doctor P. von Stein (Cologne, DE)

Access
Abstract
Slides
Like
Thumbnail

Bleeding in patients undergoing percutaneous coronary intervention: factors associated with procedural outcomes and major bleeding complications

Speaker: Doctor T. Bimal (Port Jefferson, US)

Access
Abstract
Slides
Like
Thumbnail

Prevalence and impact of TWILIGHT criteria in all-comer patients undergoing percutaneous coronary intervention

Speaker: Doctor W. Koh (New York, US)

Access
Abstract
Slides
Like
Thumbnail

Determinants of myocardial injury following transcatheter aortic valve implantation: a pre-specified substudy from the POPular TAVI trial

Speaker: Mr D. van Ginkel (Nieuwegein, NL)

Access
Abstract
Slides
Like
Thumbnail

Dual versus single antiplatelet therapy after transcatheter aortic valve replacement: a systematic review and meta-analysis

Speaker: Doctor R. Eikelboom (Hamilton, CA)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Pharmacology and bleeding/ischaemica trade-off

Speakers: Professor J. Lopez-Minguez, Doctor P. von Stein, Doctor T. Bimal, Doctor W. Koh, Mr D. van Ginkel...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources